title: Autoimmune pancytopenia following allogeneic bone marrow transplantation.
abstract: A 47-year-old female developed autoimmune hemolytic anemia, autoimmune neutropenia, and autoimmune thrombocytopenia 19 months following allogeneic bone marrow transplantation for chronic myelogenous leukemia. Treatment with high-dose corticosteroids resulted in marked improvement in all three cell lines.
authors.affiliation: Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston.
authors.forename: T R
authors.initials: TR
authors.lastname: Klumpp
authors.forename: M A
authors.initials: MA
authors.lastname: Caligiuri
authors.forename: S N
authors.initials: SN
authors.lastname: Rabinowe
authors.forename: R J
authors.initials: RJ
authors.lastname: Soiffer
authors.forename: C
authors.initials: C
authors.lastname: Murray
authors.forename: J
authors.initials: J
authors.lastname: Ritz
authors.forename: M A
authors.initials: MA
authors.lastname: Caliguri
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy / Q000209:etiology*; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000276:immunology; D005260:Female; D006789:Host vs Graft Reaction; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000601:surgery*; D008875:Middle Aged; D010198:Pancytopenia / Q000188:drug therapy / Q000209:etiology*; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000276:immunology
chemical_list: D011241:Prednisone